Peptide Receptor Radionuclide and Octreotide: A Novel Approach for Metastatic Tumor-Induced Osteomalacia

KEY MESSAGES: Octreotide can be used as an adjunctive therapy to increase phosphorus levels in patients with tumor-induced osteomalacia. Malignant phosphaturic mesenchymal tumor (PMT) may benefit from treatment with peptide receptor radionucleotide therapy. CONTEXT: The success of treatment modaliti...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Abilash, Chakraborty, Semanti, Dharmshaktu, Pramila, Tandon, Nikhil, Gupta, Yashdeep, Khadgawat, Rajesh, Jabbar, Puthiyaveettil Khadar, Bal, Chandra Sekhar, Agarwal, Shipra, Ganie, Mohd Ashraf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686685/
https://www.ncbi.nlm.nih.gov/pubmed/29264524
http://dx.doi.org/10.1210/js.2016-1088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686685/
https://www.ncbi.nlm.nih.gov/pubmed/29264524
http://dx.doi.org/10.1210/js.2016-1088

Ejemplares similares